NPC 15669 Reduces Neutrophil Activation During Heart Surgery in Pigs
Author Information
Author(s): J. M. Bator, A. M. Gillinov, K. J. Zehr, J. M. Redmond, I. C. Wilson, A. Herskowitz, J. R. Connor, R. M. Burch, D. E. Cameron
Primary Institution: Johns Hopkins Medical Institution
Hypothesis
Can NPC 15669 inhibit neutrophil activation and tissue damage during cardiopulmonary bypass in pigs?
Conclusion
The study concluded that NPC 15669 effectively inhibits neutrophil activation and reduces tissue injury during cardiopulmonary bypass.
Supporting Evidence
- NPC 15669 significantly inhibited the increase in CD18 expression on neutrophils during CPB.
- Lung tissue myeloperoxidase content was significantly lower in treated pigs compared to controls.
- Histological examination showed less neutrophil infiltration in the lungs of treated animals.
- Percentage wet weight of lung tissue was significantly lower in treated pigs, indicating less edema.
Takeaway
This study shows that a drug called NPC 15669 can help protect pig lungs from damage during heart surgery by stopping certain white blood cells from causing harm.
Methodology
Pigs were given NPC 15669 before and during cardiopulmonary bypass, and various measures of neutrophil activation and lung injury were assessed.
Limitations
The study was conducted in a pig model, which may not fully replicate human responses.
Participant Demographics
Piglets weighing 10-12 kg were used in the study.
Statistical Information
P-Value
p<0.0004
Statistical Significance
p<0.05
Want to read the original?
Access the complete publication on the publisher's website